Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.390
+0.080 (6.11%)
At close: Jan 17, 2025, 4:00 PM
1.340
-0.050 (-3.60%)
Pre-market: Jan 21, 2025, 4:49 AM EST
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 50 employees as of June 30, 2024. The number of employees decreased by 1 or -1.96% compared to the previous year.
Employees
50
Change (1Y)
-1
Growth (1Y)
-1.96%
Revenue / Employee
$63,759
Profits / Employee
-$208,344
Market Cap
6.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
INBS News
- 6 days ago - Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - GlobeNewsWire
- 3 months ago - Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Newsfile Corp
- 3 months ago - Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek - GlobeNewsWire